Chanda Sanjay insider trades
Chanda Sanjay has filed 9 Form 4s with the SEC that we hold, all for AN2 Therapeutics, Inc. (ANTX), as Chief Development Officer. Across all of them we count 0 purchases worth $0 and 3 sales worth $13.3K reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($9.3K). The largest single trade was a sale of 5,956 shares of AN2 Therapeutics, Inc. worth $6.0K, dated 2026-01-06. The first filing on our record is dated 2022-05-16 and the latest 2026-03-23.
AN2 Therapeutics, Inc. (ANTX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-01-03 | S, sale reported on Form 4 | 2,957 | $4.0K | 2025-01-07 |
| 2026-01-05 | S, sale reported on Form 4 | 3,295 | $3.3K | 2026-01-07 |
| 2026-01-06 | S, sale reported on Form 4 | 5,956 | $6.0K | 2026-01-07 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1571820) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms